Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc Balance Sheet 2021–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 763.6M | 580.6M | 526.3M | 459.7M | 232.8M |
| Cash & Equivalents | 165.6M | 183.6M | 108.0M | 122.7M | 122.5M |
| Liabilities | |||||
| Total Liabilities | 196.0M | 142.1M | 87.5M | 63.5M | 47.8M |
| Long-Term Debt | — | — | — | — | — |
| Equity | |||||
| Shareholders' Equity | 567.6M | 438.4M | 438.8M | 396.1M | 185.0M |
Kiniksa Pharmaceuticals International, plc Balance Sheet — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) balance sheet over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KNSA's balance sheet history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's balance sheet by year and by quarter, including the growth rate.